| Saggar AK and Bittles AH. | Consanguinity and Child Health. Paediatrics and Child Health. In press. 2008 |
| Griffith E, Walker S, Martin CA, Vagnarelli P, Stiff T, Vernay B, Al Sanna N, Saggar A, Hamel B, Earnshaw WC, Jeggo PA, Jackson AP, O'Driscoll M. | Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat Genet. 2008; 40(2):232-6. Epub 2007 Dec 23 |
| Davies DM, Johnson SR, Tattersfield AE, Kingswood JC, Cox JA, McCartney DL, Doyle T, Elmslie F, Saggar A, de Vries PJ, Sampson JR. | Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N Engl J Med. 2008; 10;358(2):200-3. |
| Doulton TW, Saggar-Malik AK, He FJ, Carney C, Markandu ND, Sagnella GA, MacGregor GA. | The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients. J Hypertens. 2006 May; 24(5):939-45. |
| Patel U, Simpson E, Kingswood JC, Saggar-Malik AK. | Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma. Clin Radiol. 2005 Jun;60(6):665-73; discussion 663-4. |
| Whittock NV, Izatt L, Mann A, Homfray T, Bennett C, Mansour S, Hurst J, Fryer A, Saggar A, Barwell JG, Ellard S, Clayton PT. | Novel mutations in X-linked dominant chondrodysplasia punctata (CDPX2). The Soc for Investig Derm. 2003, October, 121 (4) 939 – 942. |
| Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F, Watson ML, Bergstralh EJ, Winearls, CG, Torres VE, Harris PC. | Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 2003 June; 361 (9376) 2196-201. |
| Dong YB, Plange-Rhule J Owusu I, Micah F, Eastwood JB, Carter ND, Saggar-Malik AK, Cappuccio FP, Jeffery S. | T594M mutation of the beta-subunit of the epithelial sodium channel in Ghanaian populations from Kumasi and London and a possible association with hypertension. Genet Test. 2002 Spring; 6(1):63-65. |
| Rosseti S, Chauveau D, Walker D Saggar-Malik AK, Winearls CG, Torres VE, Harris PC. | A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int. 2002 May;61(5):1588-1599. |
| Afzal AR, Florencio RN, Taylor R, Patton MA, Saggar-Malik AK, Jeffery S. | Novel mutations in the duplicated region of the polycystic kidney disease 1 (PKD1) gene provides supporting evidence for gene conversion. Genet Test. 2000;4(4):365-370. |
| Saggar-Malik AK, Afzal AR, Swissman JS, Bland M, Sagnella GA, Eastwood JB, MacGregor GA, Jeffery S. | Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease. Genet Test. 2000; 4(3):299-303. |
| Hateboer N, Torra R, Estivill E, Bogdanova N, Davies F, Lazarou L, v Dijk M, Breuning M, Saggar-Malik A, Jeffery S, San Millan J L, Martinez I, Walker R, Holmans P, Ravine D. | Location of mutations within the PKD2 gene influences outcome. Kidney International, 2000. 57, 1444-1451 |
| Jeffery S Crosby A Plange-Rhule, J., Amoah-Danquah J., Acheampong JW., Eastwood J., Saggar-Malik AK. | Evidence from a Ghanian population of known African descent to support the proposition that haemochromatosis is a Caucasian disorder. Genetic testing 1999 3,375-378 |
| Jeffery S., Saggar-Malik AK., Crosby A., Bland M., Eastwood J., Amoah-Danquah J., Acheampong JW., Plange-Rhule, J. | A dominant relationship between the ACE-D allele and serum ACE levels in a Ghanaian population J.Med Genet 1999. 36 869-870. |
| Afzal. A. R., Hand, M., Ternes-Pereira, E., Saggar-Malik, AK., Taylor, R., Jeffery, S. | Novel Mutations in the 3’ region of the polycystic kidney disease 1 (PKD1) gene. Human Mutation. 1999. 105, 648-653. |
| Plange-Rhule, J, Phillips, R, Acheampong, JW, Saggar-Malik, AK, Eastwood. J, Cappuccio, FP | Hypertension and renal failure in Kumasi, Ghana. 1999. J Human Hypertension, 13, 37-40 |
| Hateboer, N, v Dijk M, Bogdanova N, Coto E, Jeffery S, Saggar-Malik AK, San Milan J L, Torra R, Breuning M, Holmans P, Ravine D. | Polycystic Kidney Disease types 1 and 2:a comparison of phenotypes. Lancet 9 January 1999 |
| Jeffery S, Economides DL., Saggar-Malik AK, MacDermott KD, | Apparent normalisation of fetal renal size in autosomal dominant polycystic kidney disease. Clinical Genetics 1998. 53,303-307. |
| Sagnella, GA, Saggar-Malik, AK, Buckley, MG, Markandu, ND, Eastwood, JB, MacGregor, GA. | Association between atrial natriuretic peptide and cyclic GMP in hypertension and in chronic renal failure. Clinica Chemica Acta 275, 9-18, 1998 |
| MacDermott KD, Saggar-Malik AK, Economides DL, Jeffery S. | Prenatal diagnosis for autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease J Med Genet 35 1 13-16, 1998 |
| Weston, BS, Jeffery, S, Jeffrey I, Sharaf, FA, Carter N, Saggar-Malik AK, Price, RG. | Polycystin expression during embryonic development of human kidney in adult tissues and ADPKD tissue. Histochem J 29, 847-856. 1997 |
| Saggar-Malik AK, Markandu, ND, MacGregor, GA, Cappuccio FP. | Case report: Moderate salt restriction for the management of hypertension and hypercalciuria. J Human Hypertens 10, 811-813. 1996 |
| Saggar-Malik AK. | Making the change. A guide to changing antihypertensive therapy in the elderly. (Editorial) Geriatrics, 10, 1996 |
| Saggar-Malik AK and Patton, M. A. | Original contributions by medical students. BMJ 1997 |
| Buckley MG, Saggar-Malik AK, Markandu ND, Sagnella GA, MacGregor GA. | Effects of changes in dietary sodium intake on plasma brain natriuretic peptide levels in patients with autosomal dominant polycystic kidney disease. J Hum Hyperten, 10, 1996 |
| Jeffery S, Morgan S, Warmington VJ, MacGregor GA, Saggar-Malik AK. | A family with autosomal dominant polycystic kidney disease not linked to 4q21-23 J Med Genet 1995, 32 493-94 |
| Bath PMW, Saggar-Malik AK, MacDougall I, Eastwood JB, MacGregor1995. | Increased platelet volume in autosomal dominant polycystic kidney disease Platelets 1995 6 (6): 336-339 |
| Jeffery, S, Saggar-Malik AK, Morgan, S, Eastwood, JB, Patton, M. | Genetic analysis of 20 families with autosomal dominant polycystic kidney disease from the South West Thames Region. Clinical Genetics, 1995; 77, (6) 290-4 |
| Mathiu I, Saggar-Malik AK, Carter N. | Characterisation and expression of CA-4 receptor activity in EaHY 926 (UveX) endothelial cell line. Biochemical Transactions and Proceedings 13, 635, 1995 |
| Buckenham T, Saggar-Malik AK. | Alcohol for parenchymal cysts. Australasian Radiology 1994 38: 85-86. |
| Saggar-Malik AK, Jeffery, S. and Patton, M. A. | Autosomal dominant polycystic kidney disease. (Editorial) British Medical Journal, 308: 1183-1184, 1994. |
| Saggar-Malik AK, Missouris, C. G., Gill, J. S., Singer, D. R. J., Markandu, N. D. and MacGregor, G. A | Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease. British Medical Journal 1994 309: 1617-1618. |
| Jeffery, S., Saggar-Malik AK, Morgan, S. and MacGregor, G. A. | A family with autosomal dominant polycystic kidney disease not linked to chromosome 16p 13.3. Clinical Genetics, 44: 173-176 1994 |
| Stenvinkel P, Saggar-Malik A.K. Alvestrand A. | Renal haemodynamics and tubular sodium handling following volume expansion with sodium chloride (NaCl) and glucose in healthy humans. Scand J Lab Invest 52: 837-846, 1992 |
| Stenvinkel P, Saggar-Malik AK, Wahrenberg H, Diczfalusy U, Bolinder J, Alvestrand A. | Impaired intrarenal dopamine production following intravenous sodium chloride infusion in insulin-dependent (Type 1) diabetes mellitus. Diabetologia, 34, 114-118, 1991 |
| Cundy TF Butler J, Pope RM, Saggar-Malik AK, Wheeler MJ, Williams R | Amenorrhoea in Women with Non alcoholic Chronic Liver Disease. Gut 32, 2 p 202-206. 1991 |
